Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This is a study to determine the safety and effectiveness of Darbepoetin (Aranesp) given
every 14 to 28 days to treat low red blood cells in children with chronic kidney failure.